Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
DOI:
https://doi.org/10.14739/2310-1237.2012.2.16719Keywords:
chronic viral hepatitis C, hepatic steatosis, fibrosis, liver cirrhosisAbstract
The research of pathomorphological features of liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis has shown that as opposed to cases of perisinusoidal-central-lobular and portal-septal fibrosis, typical for chronic viral hepatitis C without steatosis, in patients with chronic viral hepatitis C with steatosis in areas of maximal hepatocyte steatosis and steatic cysts firstly focal pericellular-lobular fibrosis develops which then progresses into pericellular intralobular severe liver fibrosis.References
Патологическая анатомия: курс лекций / [В.В.Серов, М.А. Пальцев, В.А. Варшавский и др.]; под ред. В.В. Серова, М.А. Пальцева. – М.: Медицина, 1998. – 640 с.
Дамианов И. Секреты патологии [пер. с англ] / И. Дамианов. – М.: ООО «Мед. информ. агентство», 2006. – 816 с.
Steven А. Core pathology / А. Steven, J.Love, I.Scott. – Third Ed. – MOSBY Elsevier, 2009. – 632 p.
Joung B. Wheaters Basic Pathology / B. Joung, W.Stevart, G.O’Dowd. – Fifth Ed. – CHURCHILL LIVINGSTONE Elsevier, 2011. – 337 p.
Вірусні гепатити і рак печінки / [М.А. Андрейчин, В.І. Дрижак, О.В. Рябоконь, В.С. Копча]. – Тернопіль: ТДМУ, 2010. – 188 с.
Duvnjak L. The metabolic syndrome – an ongoing story / L. Duvnjak, M. Duvnjak // J. Physiol. Pharmacol. – 2009. – Vol. 60, suppl. 7. – P. 19–24.
Perumalswami P. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection / P. Perumalswami, D.E. Kleiner, G.Lutchman [et al.] // Hepatology. – 2006. – Vol. 43, №4, – P. 780–787.
Enjoji M. Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments / M. Enjoji, M. Kohjima, K. Kotoh [et al.] // Int J Hepatol. – 2012. – Режим доступу: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373124/
Qiang G. Lipid Droplet Binding of Hepatitis C Virus Core Protein Genotype 3 / G. Qiang, R. Jhaveri // ISRN Gastroenterol. – 2012. – Режим доступу: http://www.ncbi.nlm.nih.gov/pubmed/22844606
Lonardo A. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease / A. Lonardo, L.E. Adinolfi, P. Loria [et al.] // Gastroenterology. – 2004. – Vol. 126, №2. – P. 586–597.
Powell E.E. Steatosis: co-factor in other liver diseases. / E.E. Powell, J.R. Jonsson, A.D. Clouston // Hepatology. – 2005. – Vol. 42, № 1. – P. 5–13.
Cross T.J. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection / T.J. Cross, A. Quaglia, S. Hughes [et al.] // J Viral Hepat. – 2009. – Vol. 16, №7. – P. 492–499.
Ripoli M Impact of HCV genetic differences on pathobiology of disease / M. Ripoli, V. Pazienza // Expert Rev Anti Infect Ther. – 2011. – Vol. 9, №9. – P. 747–759.
Hui J.M. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression / J.M. Hui, A. Sud, G.C. Farrell [et al.] // Gastroenterology. – 2003. – Vol. 125. №6. – P. 1695–1704.
Jhaveri R. Domain 3 of hepatitis C virus core protein is sufficient for intracellular lipid accumulation // R. Jhaveri, G. Qiang, A.M. Diehl // J Infect Dis. – 2009. –Vol. 200, №11. – P. 1781–1788.
Kleiner D.E. Decision and validation of a histological scoring system for nonalcoholic fatty liver disease / D.E. Kleiner, E.M. Brunt, M. van Natta [et al.] // Hepatology. – 2005. – Vol.41. – P. 1313–1321.
Степанов Ю.М. Стеатоз печени и неалкогольный стеатогепатит: современный взгляд на патогенез, диагностику и лечение / Ю.М. Степанов, А.Ю. Филиппова // Здоров’я України. – 2004. – №103. – Режим доступу: http://health-ua.com/articles/977.html
Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells / R. Bataller, Y.H. Paik, J.N. Lindquist [et al.] // Gastroenterology. – 2004. – №126. – P. 529–540.
Туманский В.А. Иммуноклеточный киллинг: морфогенез и последствия для больных хроническим вирусным гепатитом / В.А. Туманский, М.А. Шишкин, Ю.А. Шебеко // Патологія. – 2008. – Т. 5, №3 – С. 110–112.
Туманский В.А. Патогенно индуцированный апоптоз гепатоцитов при хроническом вирусном гепатите: молекулярные механизмы и микроскопическая диагностика / В.А. Туманский, Ю.А. Шебеко // Патологія. – 2008. – Т. 5, №3 – С. 29–34.
Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases / J.C. Bonner // Cytokine Growth Factor Rev. – 2004. – Vol. 15, №4. – P. 255–273.
Ghatak S. Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice / S. Ghatak , A. Biswas, G.K. Dhali [et al.] // Toxicol. Appl. Pharmacol. – 2010. – Vol. 251, №1. – Р. 59–69.
Gieling R.G. Fibrosis and cirrhosis reversibility - molecular mechanisms / R.G. Gieling, A.D. Burt, D.A. Mann // Clin. Liver Dis. – 2008. – Vol. 12, Iss. 4. – P. 915–937.
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition / M. Zeisberg, C. Yang, M. Martino [et al.] // J. Biol. Chem. – 2007. – Vol. 282. – P. 23337–23347.
Шебеко Ю.А. Особенности морфогенеза и прогрессии фиброза и цирроза печени у больных хроническим вирусным гепатитом С: автореф. дис. … к. мед. наук: спец. 14.03.02 «Патологическая анатомия» / Ю.А. Шебеко – З., 2011. – 22 с.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
